Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-46 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
filingDate |
1986-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1990-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d790c8d87cc6fd371500ee7f7ceae6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1677d6e0caf1d8a78579f26bd1199019 |
publicationDate |
1990-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4923975-A |
titleOfInvention |
Valiolamine derivatives and production thereof |
abstract |
A novel valiolamine derivative of the formula (I): ##STR1## where R stands for hydrogen or β-D-glucopyranosyl group is useful for a starting material of valiolamine which can be converted to more potent α-glucosidase inhibiting compounds. The valiolamine derivative is obtained by cultivating Streptomyces hygroscopics in a culture medium and recovering the valiolamine derivative produced and accumulated from the culture broth. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022187361-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113321591-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100369911-C |
priorityDate |
1985-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |